1.
Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
by Tang, W.H. Wilson, MD
The American journal of cardiology, 2011, Vol.108 (3), p.385-390

2.
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (From the Treating to New Targets [TNT] Study)
by Shepherd, James, MD
The American journal of cardiology, 2015, Vol.117 (8), p.1199-1205

3.
Outcomes and Worsening Renal Function in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction
by Sharma, Kavita, MD
The American journal of cardiology, 2015, Vol.116 (10), p.1534-1540

4.
Effects of Atorvastatin and Rosuvastatin on Renal Function in Patients With Type 2 Diabetes Mellitus
by Lai, Chao-Lun, MD, PhD
The American journal of cardiology, 2015, Vol.115 (5), p.619-624

5.
Influence of Age-Related Versus Non–Age-Related Renal Dysfunction on Survival in Patients With Left Ventricular Dysfunction
by Testani, Jeffrey M., MD, MTR
The American journal of cardiology, 2014, Vol.113 (1), p.127-131

6.
Relation of Improvement in Estimated Glomerular Filtration Rate With Atorvastatin to Reductions in Hospitalizations for Heart Failure (from the Treating to New Targets [TNT] Study)
by Ho, Jennifer E., MD
The American journal of cardiology, 2012, Vol.109 (12), p.1761-1766

7.
Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A
by Lang, Chim C
The American journal of cardiology, 1993, Vol.72 (14), p.1083-1084

8.
Extracellular and interstitial fluid volume in obesity with and without associated systemic hypertension
by Raison, Jocelyne
The American journal of cardiology, 1986, Vol.57 (4), p.223-226
